ICP-OES Webinar
In this webinar we will focus on Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES), and ICP-MS
Principles and Strengths of In Vitro Testing
Principles of In Vitro Testing
In vitro is the Latin term for “in glass,” meaning that the testing is performed in a container that is outside of a living organism. This testing uses cell-based biological models instead of animals or humans. In vitro efforts help fulfil the FDA’s “3Rs approach” to replace, reduce, and/or refine animal testing.
Replace
- Develop and explore tests that replace the need for animal models.
Reduce
- Minimize the number of animal models in experimentation.
Refine
- Reduce the suffering and stress of laboratory animals and improve their wellbeing.
In Vitro model systems can be specified to the test sample’s intended use. 2D cell cultures are grown rapidly for high-throughput or multi-sample analysis with minimized variation between treatments. Cell cultures can also be made into 3D tissue models. These models contain differentiated cell layers to physiologically represent complex tissues and evaluate specific endpoints. Using specific geometries, in vitro cell culture models can be used to evaluate simple and complex biological responses.
To assess different biological endpoints, various forms of analytical methods may be implemented. Measurable responses of the in vitro models include cell death, growth inhibition, genetic alterations, changes in surface marker expression and altered metabolism.
Technical Specifications
- Cytotoxicity
- Qualitative evaluation of cell cultures under a microscope
- Quantification of cell morphology and growth via automated cytotoxicity scoring
- Quantification using a cell viability reagent, measured by a spectrophotometer
- Irritation
- Quantification using a cell viability reagent, measured by a spectrophotometer
Strengths of In Vitro Testing
- Rapid results
- Suitable for high throughput testing
- Economically and ethically favorable compared to animal testing
- Minimized presence of biological variables
- 3D tissues results include the effects of cell-cell interaction
- Several endpoints can be measured
- Customization of study details during early-stage sample development
Limitations of In Vitro Testing
- Not all models account for the impact of complex physiological systems such as hormones and immunity
- Some in vitro models for biological endpoint assessment may not be accepted by all regulatory bodies
- Cannot identify mechanisms that lead to adverse biological results without further testing or chemical characterization
Related Resources
- Brochure: In Vitro Biocompatibility Testing
- Service: In Vitro Biocompatibility
- Service: In Vitro Skin Irritation Testing
- Service: In Vitro Cytotoxicity Testing
- Industry: Medical Devices
- Blog: Frequently Asked Questions About In Vitro Irritation and Cytotoxicity Testing
- Blog: The Conspicuous Case of the Missing T0 in ISO 10993-5 Cytotoxicity Testing
- Application Note: Next Steps After Receiving a Cytotoxic Result
More content you might like...
2D and 3D Investigations of Li-Ion Battery Electrodes
Li-Ion electrodes are more than just energy suppliers; they’re intricate mazes of structures and materials. Their design and intricate layout play pivotal roles in determining a battery’s capacity, discharge rate, and overall lifespan.
Food Packaging Materials Testing
Food packaging materials can be made with plastics, paper and board, glass, metal, wax, and printing inks. These packaging materials are directly and indirectly in contact with our food.
Plasma FIB – A better alternative to traditional FIB?
PFIB differs from traditional FIB in that it uses various gases such as Xe, Ar, oxygen or nitrogen to generate a plasma that is used to remove material from a sample.